Axalta Exceeds Q1 Guidance with Strong Cash Flow; Provides Q2 and Full-Year 2026 Outlook
Summary
Axalta Coating Systems announced first-quarter 2026 financial results, exceeding its guidance for key metrics and reporting record cash flow, while also providing its outlook for the second quarter and full year.
Key Events
-
Exceeded Q1 Guidance
Axalta surpassed its guidance for first-quarter net sales, Adjusted EBITDA ($259 million), and Adjusted Diluted EPS ($0.56).
-
Record Cash Flow Generation
The company reported record first-quarter cash provided by operating activities of $68 million and record free cash flow of $21 million, both significantly up year-over-year.
-
Provided Q2 and Full-Year 2026 Outlook
Axalta projects Q2 2026 Adjusted Diluted EPS of approximately $0.65 and full-year 2026 Adjusted Diluted EPS between $2.55 and $2.70, with full-year free cash flow expected to be over $500 million.
-
Progress on AkzoNobel Merger
Management confirmed that workstreams associated with the proposed merger of equals with AkzoNobel are progressing as planned and are on track with the stated timeline.
Analysis
Axalta Coating Systems reported first-quarter results that surpassed its own guidance for net sales, Adjusted EBITDA, and Adjusted Diluted EPS, demonstrating operational strength despite a dynamic macroeconomic environment. The company also achieved record first-quarter cash flow from operations and free cash flow, indicating improved liquidity and financial health. While some year-over-year metrics saw declines, the beat on expectations and robust cash generation are positive signals. The updated guidance for Q2 and full-year 2026 provides investors with a clearer forward-looking picture, and the company confirmed it is on track with the proposed merger of equals with AkzoNobel, a significant strategic event previously disclosed.
At the time of this filing, AXTA was trading at $28.21 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $24.94 to $35.72. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.